✦ LIBER ✦

Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital

✍ Scribed by N. Saltoglu; A. Dalkiran; T. Tetiker; H. Bayram; Y. Tasova; C. Dalay; M. Sert

Book ID: 111110008
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 89 KB
Volume: 16
Category: Article
ISSN: 1198-743X
DOI: 10.1111/j.1469-0691.2009.03067.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ertapenem versus piperacillin/tazobactam

Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial

✍ Benjamin A Lipsky; David G Armstrong; Diane M Citron; Alan D Tice; David E Morge 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 135 KB

Efficacy and tolerability of piperacilli

Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial

✍ F. Álvarez-Lerma; J. Insausti-Ordeñana; R. Jordá-Marcos; E. Maraví-Poma; A. Torr 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 329 KB

Early use of imipenem/cilastatin and van

Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial

✍ Jong Wook Kim; Joowon Chung; Sang-Ho Choi; Hang Jea Jang; Sang-Bum Hong; Chae-Ma 📂 Article 📅 2012 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 241 KB